Blastomycosis and Pregnancy: An Unusual Postpartum Disease Course

Blastomyces dermatitidis is responsible for systemic mycoses. It is predominantly caused by inhalation of spores and often manifests as pneumonia, which can potentially disseminate; however, direct cutaneous inoculation may also occur. Blastomycosis in the perigravid period is exceedingly rare. The...

Full description

Bibliographic Details
Main Authors: David Surprenant, Monika Kaniszewska, Kelli Hutchens, Christine Go, Paul O'Keefe, James Swan, Rebecca Tung
Format: Article
Language:English
Published: Karger Publishers 2015-05-01
Series:Case Reports in Dermatology
Subjects:
Online Access:http://www.karger.com/Article/FullText/431033
id doaj-8a4b280194b24ce79d036942b9bf7079
record_format Article
spelling doaj-8a4b280194b24ce79d036942b9bf70792020-11-24T23:18:43ZengKarger PublishersCase Reports in Dermatology1662-65672015-05-017210711210.1159/000431033431033Blastomycosis and Pregnancy: An Unusual Postpartum Disease CourseDavid SurprenantMonika KaniszewskaKelli HutchensChristine GoPaul O'KeefeJames SwanRebecca TungBlastomyces dermatitidis is responsible for systemic mycoses. It is predominantly caused by inhalation of spores and often manifests as pneumonia, which can potentially disseminate; however, direct cutaneous inoculation may also occur. Blastomycosis in the perigravid period is exceedingly rare. The partial immunosuppressive state induced by pregnancy can engender more severe infections and is associated with a risk of vertical transmission. Published cases describe postpartum symptomatic improvement accompanying immune reconstitution, even in the absence of treatment. We present a 31-year-old gravid female with multifocal cutaneous blastomycosis. After delivering a healthy full-term infant with no evidence of congenital infection, the patient's cutaneous lesions continued to worsen. At 6 weeks postpartum she was treated with oral itraconazole and demonstrated clinical improvement after 5 months of therapy. This case highlights the importance of prompt disease recognition, understanding of risk factors and initiation of appropriate antifungal therapy of blastomycotic infection occurring in the unique setting of pregnancy.http://www.karger.com/Article/FullText/431033BlastomycosisCutaneousPregnancy
collection DOAJ
language English
format Article
sources DOAJ
author David Surprenant
Monika Kaniszewska
Kelli Hutchens
Christine Go
Paul O'Keefe
James Swan
Rebecca Tung
spellingShingle David Surprenant
Monika Kaniszewska
Kelli Hutchens
Christine Go
Paul O'Keefe
James Swan
Rebecca Tung
Blastomycosis and Pregnancy: An Unusual Postpartum Disease Course
Case Reports in Dermatology
Blastomycosis
Cutaneous
Pregnancy
author_facet David Surprenant
Monika Kaniszewska
Kelli Hutchens
Christine Go
Paul O'Keefe
James Swan
Rebecca Tung
author_sort David Surprenant
title Blastomycosis and Pregnancy: An Unusual Postpartum Disease Course
title_short Blastomycosis and Pregnancy: An Unusual Postpartum Disease Course
title_full Blastomycosis and Pregnancy: An Unusual Postpartum Disease Course
title_fullStr Blastomycosis and Pregnancy: An Unusual Postpartum Disease Course
title_full_unstemmed Blastomycosis and Pregnancy: An Unusual Postpartum Disease Course
title_sort blastomycosis and pregnancy: an unusual postpartum disease course
publisher Karger Publishers
series Case Reports in Dermatology
issn 1662-6567
publishDate 2015-05-01
description Blastomyces dermatitidis is responsible for systemic mycoses. It is predominantly caused by inhalation of spores and often manifests as pneumonia, which can potentially disseminate; however, direct cutaneous inoculation may also occur. Blastomycosis in the perigravid period is exceedingly rare. The partial immunosuppressive state induced by pregnancy can engender more severe infections and is associated with a risk of vertical transmission. Published cases describe postpartum symptomatic improvement accompanying immune reconstitution, even in the absence of treatment. We present a 31-year-old gravid female with multifocal cutaneous blastomycosis. After delivering a healthy full-term infant with no evidence of congenital infection, the patient's cutaneous lesions continued to worsen. At 6 weeks postpartum she was treated with oral itraconazole and demonstrated clinical improvement after 5 months of therapy. This case highlights the importance of prompt disease recognition, understanding of risk factors and initiation of appropriate antifungal therapy of blastomycotic infection occurring in the unique setting of pregnancy.
topic Blastomycosis
Cutaneous
Pregnancy
url http://www.karger.com/Article/FullText/431033
work_keys_str_mv AT davidsurprenant blastomycosisandpregnancyanunusualpostpartumdiseasecourse
AT monikakaniszewska blastomycosisandpregnancyanunusualpostpartumdiseasecourse
AT kellihutchens blastomycosisandpregnancyanunusualpostpartumdiseasecourse
AT christinego blastomycosisandpregnancyanunusualpostpartumdiseasecourse
AT paulokeefe blastomycosisandpregnancyanunusualpostpartumdiseasecourse
AT jamesswan blastomycosisandpregnancyanunusualpostpartumdiseasecourse
AT rebeccatung blastomycosisandpregnancyanunusualpostpartumdiseasecourse
_version_ 1725580404893679616